Hutch News

Hutch News

Stories tagged 'gvhd'

‘Article of the Year’ nod to demo of machine learning for personalized medicine

Computer-generated algorithms could guide prevention, treatment of transplant complication, researchers showed

April 17, 2018 | By Susan Keown / Fred Hutch News Service

In its April issue, the American Journal of Epidemiology recognized a paper by Fred Hutchinson Cancer Research Center faculty member Dr. Elizabeth Krakow as one of its 10 best articles published in 2017.

View story >


What’s new in combatting chronic graft-vs.-host disease

Decades after the development of bone marrow transplant, researchers are making headway against one of its most common and deadly side effects

April 2, 2018 | By Rachel Tompa / Fred Hutch News Service

Up to 40% of transplant recipients develop chronic graft-vs.-host disease, which can last for years. But chronic GVHD is treatable, and new therapies and preventive measures are arriving and being tested in trials.

View story >


An opening night for heroes

Cancer survivor Rose Ibarra to be honored by Fred Hutch and Mariners at Safeco Field

March 29, 2018 | By Sabin Russell / Fred Hutch News Service

A two-time survivor of acute lymphoblastic leukemia, Rose Ibarra of West Seattle is the first of nine “Hutch Heroes” to be honored by the Mariners and Fred Hutch during Thursday home games this season.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 4, 2018

Increasing access to stem cell transplants; improving survival, QOL for those with scleroderma; biostatistician named chair-elect of AAAS Section on Statistics.

View story >


Fred Hutch/SCCA transplant patient survival above the expected rate in U.S.

For 5th year in a row, bone marrow transplant program receives top recognition

Dec. 22, 2017 | By Molly McElroy

For the fifth year in a row, the Fred Hutch Bone Marrow Transplant Program at Seattle Cancer Care Alliance has been recognized by the Center for International Blood and Marrow Transplant Research as exceeding expectations for one-year survival rates. These survival rates specifically pertain to patients who have received transplants of blood-forming stem cells from healthy donors, a procedure pioneered at Fred Hutch.

View story >


Stem cell transplantation physician-scientist recruited from Australia to join Fred Hutch, SCCA

Dr. Geoffrey Hill will help integrate bone marrow transplantation with emerging cancer immunotherapies

Dec. 7, 2017 | By Molly McElroy

Fred Hutchinson Cancer Research Center is appointing world-renowned blood stem cell transplantation physician-scientist Dr. Geoffrey Hill to be director of Hematopoietic Stem Cell Transplantation, effective July 1.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.